Baylor Genetics’ Chief Medical Officer Dr. Christine Eng explains how RNA sequencing complements DNA testing to unlock diagnoses for rare disease patients.
All in Scientist
#383 Inside the Brazilian Rare Genomes Project
How whole genome sequencing is transforming rare disease diagnosis in Brazil featuring MGI’s Victor Camillo and Neogenomica’s Dr. João Bosco Oliveira.
#382 “The Persistence Lab” Episode 1 — Can We Find Cures Faster?
Listen to The Persistence Lab, a new podcast from AbbVie. Hosted by Kira Dineen, the series explores how scientists, patients, and experts look to solve some of the toughest challenges in medicine and health care, one step at a time.
#381 Charles Darwin’s Legacy: What He Got Right & What Science Learned Next
Recorded live at Connecticut’s Darwin Day Event, we examine natural selection, horizontal gene transfer, and how Charles Darwin’s ideas continue to shape genomic science.
#379 Global Cancer Diagnostics: Building High-Quality Cancer Genomic Testing
Experts from IPATIMUP, MGI Tech, and Gene+ explain how gene panels, RNA sequencing, and automation are shaping real-world cancer care around the world.
#364 Breast Cancer Genetic Testing in Italy: A Curated Gene Panel
How Italy is integrating cancer genetic testing into its public healthcare system through Negedia’s panels, powered by MGI Tech.
#362 Optical Genome Mapping: Detecting Structural Variants Missed by Traditional Tests
Greenwood Genetics Center’s Dr. Nikhil Sahajpal reveals how OGM is changing clinical diagnostics from missed structural variants to new gene disease association.
#358 AGBT Precision Health 2025 Meeting Recaps and Reflections
Drs. Christine Eng, Eric Green, and Marina Sirota share highlights of their presentations at this week’s AGBT Precision Health 2025 Meeting in California.
#355 How Genomics Is Transforming Rare Disease Diagnosis in Turkey
Explore how MGI’s genomic innovation is transforming rare diseases (and even dual diagnoses) care in Turkey and around the globe from Dr. Serdar Ceylaner and Alice Peng.
#354 How Pharmacogenomics is Revolutionizing Drug Prescriptions
Quest Diagnostics' Kristy Bouvier and Kathleen O’Brien explore how pharmacogenetics testing can optimize medications, prevent side effects, and improve treatment.
#353 Advancing Telomere Research: A Breakthrough Leads to Clinical Trial
Live from NYC’s Cocktails & Chromosomes, patient advocate Jena Robertson and researcher Dr. Will Mannherz share personal stories and new breakthroughs bringing telomere biology disorders to a clinical trial this fall.
#335 Neanderthals, Denisovans, and Us: How DNA Reveals Evolution
Mitochondrial Eve, Neanderthal genes, and the Out of Africa theory—explained by one of the pioneers of PCR, Dr. Henry Erlich.
#329 Preventive Genomic Medicine: Saving Lives and Healthcare Costs with MyOme
Shifting healthcare from reactive to proactive, Dr. Matthew Rabinowitz breaks down how preventive genomic medicine can save $200 billion annually in healthcare costs.
#328 Breakthrough Biotech: CAR-Ts for Solid Tumors & Engineered Bacteria for Rare Diseases
Interviews recorded at BIO’s CEO and Investor Conference with two biotech executives: Cellinfinty Bio’s Dr. Premal Patel and Azitra’s Dr. Travis Whitfill.
#326 How DNA Solves Crimes: The Forensic Science Behind True Crime
Dr. Henry Erlich on DNA Evidence, Exonerations, and Ethical Dilemmas.
#320 Genetics in Neuromuscular Disorders: Diagnosis and Treatment with Dr. Robert Bucelli
“It Happened To Me” episode featuring Dr. Robert Bucelli on the role of genetics in diagnosing and treating neuromuscular disorders.
#318 Genetics Wrapped 2024: Top Advances in Genomic Medicine
Drs. Eric Green and Bruce Gelb join our host Kira Dineen for our annual reflection and recap on the biggest genetics/genomics advancements this year!
#313 Becker Muscular Dystrophy Clinical Trials with Edgewise Therapeutics
Dr. Joanne Donovan, Chief Medical Officer at Edgewise Therapeutics, discusses Becker Muscular Dystrophy (Becker) and emerging treatments.
#306 NIH’s Dr. Francis Collins’ Leadership in the Human Genome Project and COVID-19
The former NIH Director shares about his brand new book, The Road To Wisdom, including leading the Human Genome Project, COVID-19 pandemic, and more.
#303 RNA Analysis with Ambry Genetics
Dr. Rachid Karam explains how RNA testing increases diagnostic yield and reduces variants of uncertain significance in cancer and exomes.